Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Sponsor: Ohio State University Comprehensive Cancer Center
Listed as NCT01696760, this NA trial focuses on Bone Metastases and Musculoskeletal Cancer and remains completed. Sponsored by Ohio State University Comprehensive Cancer Center, it has been updated 10 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2019 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .